Seminars in Perinatology
Volume 34, Issue 3 , Pages 211-221 , June 2010

Mechanisms of Inflammatory Lung Injury in the Neonate: Lessons from a Transgenic Mouse Model of Bronchopulmonary Dysplasia

References 

  1. Korhonen P, Koivisto AM, Ikonen S, et al. Very low birthweight, bronchopulmonary dysplasia and health in early childhood. Acta Paediatr. 1999;88:1385–1391
  2. Jacob SV, Coates AL, Lands LC, et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr. 1998;133:193–200
  3. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:e141–e148
  4. Coalson JJ, Winter VT, Siler-Khodr T, et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med. 1999;160:1333–1346
  5. Ogden BE, Murphy S, Saunders GC, et al. Lung lavage of newborns with respiratory distress syndrome (Prolonged neutrophil influx is associated with bronchopulmonary dysplasia). Chest. 1983;83:31S–33S
  6. Merritt TA, Cochrane CG, Holcomb K, et al. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome (Role of inflammation in the pathogenesis of bronchopulmonary dysplasia). J Clin Invest. 1983;72:656–666
  7. Speer CP. Inflammation and bronchopulmonary dysplasia: A continuing story. Semin Fetal Neonatal Med. 2006;11:354–362
  8. Paananen R, Husa AK, Vuolteenaho R, et al. Blood cytokines during the perinatal period in very preterm infants: Relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr. 2009;154:39–43e33
  9. Ambalavanan N, Carlo WA, D'Angio CT, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birthweight infants. Pediatrics. 2009;123:1132–1141
  10. Willet KE, Jobe AH, Ikegami M, et al. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Review. 2000;48:782–788
  11. Cao L, Wang J, Tseu I, et al. Maternal exposure to endotoxin delays alveolarization during postnatal rat lung development. Am J Physiol Lung Cell Mol Physiol. 2009;296:L726–L737
  12. Gras-Le Guen C, Denis C, Franco-Montoya ML, et al. Antenatal infection in the rabbit impairs post-natal growth and lung alveolarisation. Eur Respir J. 2008;32:1520–1528
  13. Kotecha S, Wilson L, Wangoo A, et al. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Review. 1996;40:250–256
  14. Bry K, Whitsett JA, Lappalainen U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol. 2007;36:32–42
  15. Been JV, Debeer A, van Iwaarden JF, et al. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Review. 2010;67:83–89
  16. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12–24
  17. Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005;31:599–621
  18. Ekekezie II, Thibeault DW, Simon SD, et al. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics. 2004;113:1709–1714
  19. Sweet DG, Curley AE, Chesshyre E, et al. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr. 2004;93:791–796
  20. Curley AE, Sweet DG, Thornton CM, et al. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: Implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol. 2003;188:871–875
  21. Dik WA, van Kaam AH, Dekker T, et al. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonate. 2006;89:6–14
  22. Tambunting F, Beharry K, Hartleroad J, et al. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol. 2005;39:5–14
  23. Chetty A, Cao G-J, Severgnini M, et al. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol. 2008;295:L584–L592
  24. Hosford G, Fang X, Olson DM. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: Association with arrested alveolarization. Pediatr Rev. 2004;56:26–34
  25. Albaiceta GM, Gutierrez-Fernandez A, Parra D, et al. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;294:L535–L543
  26. Lukkarinen H, Hogmalm A, Lappalainen U, et al. Matrix metalloproteinase_9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 2009;41:59–68
  27. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med. 1997;214:27–40
  28. Kotecha S, Wangoo A, Silverman M, et al. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr. 1996;128:464–469
  29. Lecart C, Cayabyab R, Buckley S, et al. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate. 2000;77:217–223
  30. Gauldie J, Galt T, Bonniaud P, et al. Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol. 2003;163:2575–2584
  31. Vicencio AG, Lee CG, Cho SJ, et al. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: A new model for bronchopulmonary dysplasia?. Am J Respir Cell Mol Biol. 2004;31:650–656
  32. Kunzmann S, Speer CP, Jobe AH, et al. Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol. 2007;292:L223–L231
  33. Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest. 2001;107:1537–1544
  34. Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319–328
  35. Breuss JM, Gallo J, DeLisser HM, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108:2241–2251
  36. Ganter MT, Roux J, Miyazawa B, et al. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circ Res. 2008;102:804–812
  37. Hogmalm A, Sheppard D, Lappalainen U, et al: Beta6 integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol, in press
  38. Webb DC, McKenzie AN, Foster PS. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: Identification of a novel allergy-associated protein. J Biol Chem. 2001;276:41969–41976
  39. Iwashita H, Morita S, Sagiya Y, et al. Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 2006;35:103–109
  40. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–1507
  41. Andrews WW, Hauth JC, Goldenberg RL, et al. Amniotic fluid interleukin-6: Correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol. 1995;173:606–612
  42. Goldenberg RL, Culhane JF. Preterm birth and periodontal disease. N Engl J Med. 2006;355:1925–1927
  43. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33:S390–S397
  44. Gravett MG, Witkin SS, Haluska GJ, et al. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol. 1994;171:1660–1667
  45. Novy MJ, Duffy L, Axthelm MK, et al. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci. 2009;16:56–70
  46. Bry K, Hallman M. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1alpha and tumor necrosis factor-alpha in the rabbit. Am J Obstet Gynecol. 1993;168:1318–1322
  47. Sadowsky DW, Adams KM, Gravett MG, et al. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol. 2006;195:1578–1589
  48. Ghidini A, Jenkins CB, Spong CY, et al. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol. 1997;37:227–231
  49. Wenstrom KD, Andrews WW, Hauth JC, et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998;178:546–550
  50. Perni SC, Vardhana S, Korneeva I, et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol. 2004;191:1382–1386
  51. Gerber S, Vial Y, Hohlfeld P, et al. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis. 2003;187:518–521
  52. Grigsby PL, Novy MJ, Waldorf KM, et al. Choriodecidual inflammation: A harbinger of the preterm labor syndrome. Reprod Sci. 2010;17:85–94
  53. Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics. 1999;103:759–765
  54. Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97:210–215
  55. Andrews WW, Goldenberg RL, Faye-Petersen O, et al. The Alabama preterm birth study: Polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23 to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803–808
  56. Dempsey E, Chen MF, Kokottis T, et al. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005;22:155–159
  57. Kaukola T, Tuimala J, Herva R, et al. Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol. 2009;200:e101–e108
  58. Richardson BS, Wakim E, daSilva O, et al. Preterm histologic chorioamnionitis: Impact on cord gas and pH values and neonatal outcome. Am J Obstet Gynecol. 2006;195:1357–1365
  59. Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: A 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed. 2009;94:F13–F16
  60. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest. 1997;99:2992–2999
  61. Jobe AH, Newnham JP, Willet KE, et al. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol. 2000;182:401–408
  62. Moss TJ, Knox CL, Kallapur SG, et al. Experimental amniotic fluid infection in sheep: Effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep. Am J Obstet Gynecol. 2008;198:e121–e128
  63. Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102–109
  64. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Review. 2004;55:1009–1017
  65. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997;177:825–830
  66. Kent A, Dahlstrom JE. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia. J Paediatr Child Health. 2004;40:356–359
  67. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birthweight infants. Pediatr Rev. 2002;52:713–719
  68. Van Marter LJ, Dammann O, Allred EN, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002;140:171–176
  69. Matsuda T, Nakajima T, Hattori S, et al. Necrotizing funisitis: Clinical significance and association with chronic lung disease in premature infants. Am J Obstet Gynecol. 1997;177:1402–1407
  70. Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: A 13-year hospital cohort study. Pediatrics. 2009;123:1314–1319
  71. Backstrom E, Lappalainen U, Bry K. Maternal IL-1beta production prevents lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol. 2010;42:149–160

 This work was supported by the Swedish Medical Research Council (K.B.), the Swedish Heart and Lung Foundation (K.B.), the Frimurare Barnhus Foundation (K.B.), the Swedish Government Grants for Medical Research (K.B.), and the Queen Silvia Children's Hospital Research Foundation (A.H. and E.B.).

PII: S0146-0005(10)00020-0

doi: 10.1053/j.semperi.2010.02.006

Seminars in Perinatology
Volume 34, Issue 3 , Pages 211-221 , June 2010

Article Tools

* Image Usage & Resolution